Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (201-210 of 635) with videos related to

Pageof 64
Sort By:
Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
American Heart Journal|October 17, 2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess, Samuel Broderick, Jonathan P Piccini, et al.
Cardiology and Therapy|October 15, 2025
Digital Strategies for Recruitment to Improve Diversity and Inclusion in Prospective Cardiovascular Clinical ResearchSneha S Jain, Fatima Rodriguez, Marco V Perez, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
Journal of the American Heart Association|June 11, 2018
Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AFEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Circulation|December 16, 2014
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Eric D Peterson, Sunghee Kim, et al.
Pageof 64

Showing results (201-210 of 635) with videos related to

Sort By:
Pageof 64
Diabetes, Obesity & Metabolism|October 12, 2020
Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomesBrendon L Neuen, Clare Arnott, Vlado Perkovic, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
Kidney International|March 27, 2024
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysisWolfgang C Winkelmayer, Anthonie W A Lensing, Ravi I Thadhani, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
American Heart Journal|October 17, 2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess, Samuel Broderick, Jonathan P Piccini, et al.
Cardiology and Therapy|October 15, 2025
Digital Strategies for Recruitment to Improve Diversity and Inclusion in Prospective Cardiovascular Clinical ResearchSneha S Jain, Fatima Rodriguez, Marco V Perez, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
Journal of the American Heart Association|June 11, 2018
Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AFEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Circulation|December 16, 2014
Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Eric D Peterson, Sunghee Kim, et al.
Pageof 64